메뉴 건너뛰기




Volumn 19, Issue 5, 2012, Pages 297-302

Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients

Author keywords

Acute renal impairment; Light chain; Multiple myeloma; Myeloma kidney

Indexed keywords

BORTEZOMIB; CALCITONIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FUROSEMIDE; GLUCOCORTICOID; IMMUNOGLOBULIN LIGHT CHAIN; LENALIDOMIDE; MELPHALAN; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; TAMM HORSFALL GLYCOPROTEIN; THALIDOMIDE;

EID: 84865411713     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2012.06.001     Document Type: Review
Times cited : (18)

References (46)
  • 1
    • 0028135393 scopus 로고
    • Renal function in newly diagnosed multiple myeloma-a demographic study of 1353 patients
    • The Nordic Myeloma Study Group, 1994
    • Knudsen L.M., Hippe E., Hjorth M., et al. Renal function in newly diagnosed multiple myeloma-a demographic study of 1353 patients. Eur J Haematol 1994, 53:207-212. The Nordic Myeloma Study Group, 1994.
    • (1994) Eur J Haematol , vol.53 , pp. 207-212
    • Knudsen, L.M.1    Hippe, E.2    Hjorth, M.3
  • 2
    • 0033851432 scopus 로고    scopus 로고
    • Renal failure in multiple myeloma: reversibility and impact on the prognosis
    • Nordic Myeloma Study Group
    • Knudsen L.M., Hjorth M., Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Eur J Haematol 2000, 65:175-181. Nordic Myeloma Study Group.
    • (2000) Eur J Haematol , vol.65 , pp. 175-181
    • Knudsen, L.M.1    Hjorth, M.2    Hippe, E.3
  • 3
    • 0032575885 scopus 로고    scopus 로고
    • Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution
    • Blade J., Fernandez-Llama P., Bosch F., et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 1998, 158:1889-1893.
    • (1998) Arch Intern Med , vol.158 , pp. 1889-1893
    • Blade, J.1    Fernandez-Llama, P.2    Bosch, F.3
  • 4
    • 79951891171 scopus 로고    scopus 로고
    • Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group
    • Dimopoulos M.A., Terpos E., Chanan-Khan A., et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 2010, 28:4976-4984.
    • (2010) J Clin Oncol , vol.28 , pp. 4976-4984
    • Dimopoulos, M.A.1    Terpos, E.2    Chanan-Khan, A.3
  • 5
    • 33748692003 scopus 로고    scopus 로고
    • Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK Multiple Myeloma Trials
    • Drayson M., Begum G., Basu S., et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK Multiple Myeloma Trials. Blood 2006, 108:2013-2019.
    • (2006) Blood , vol.108 , pp. 2013-2019
    • Drayson, M.1    Begum, G.2    Basu, S.3
  • 6
    • 84455205655 scopus 로고    scopus 로고
    • The pathogenesis and diagnosis of acute kidney injury in multiple myeloma
    • Hutchison C.A., Batuman V., Behrens J., et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 2012, 8:43-51.
    • (2012) Nat Rev Nephrol , vol.8 , pp. 43-51
    • Hutchison, C.A.1    Batuman, V.2    Behrens, J.3
  • 7
    • 0025020662 scopus 로고
    • Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins
    • Sanders P.W., Booker B.B., Bishop J.B., et al. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest 1990, 85:570-576.
    • (1990) J Clin Invest , vol.85 , pp. 570-576
    • Sanders, P.W.1    Booker, B.B.2    Bishop, J.B.3
  • 8
    • 0026607225 scopus 로고
    • Pathobiology of cast nephropathy from human Bence Jones proteins
    • Sanders P.W., Booker B.B. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 1992, 89:630-639.
    • (1992) J Clin Invest , vol.89 , pp. 630-639
    • Sanders, P.W.1    Booker, B.B.2
  • 9
    • 77951686835 scopus 로고    scopus 로고
    • Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus
    • Cairo M.S., Coiffier B., Reiter A., et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010, 149:578-586.
    • (2010) Br J Haematol , vol.149 , pp. 578-586
    • Cairo, M.S.1    Coiffier, B.2    Reiter, A.3
  • 10
    • 43749109850 scopus 로고    scopus 로고
    • Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains
    • Leung N., Gertz M.A., Zeldenrust S.R., et al. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int 2008, 73:1282-1288.
    • (2008) Kidney Int , vol.73 , pp. 1282-1288
    • Leung, N.1    Gertz, M.A.2    Zeldenrust, S.R.3
  • 11
    • 66449132961 scopus 로고    scopus 로고
    • Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis
    • Hutchison C.A., Bradwell A.R., Cook M., et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 2009, 4:745-754.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 745-754
    • Hutchison, C.A.1    Bradwell, A.R.2    Cook, M.3
  • 12
    • 79958846304 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of multiple myeloma 2011
    • Bird J.M., Owen R.G., D'Sa S., et al. Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol 2011, 154:32-75.
    • (2011) Br J Haematol , vol.154 , pp. 32-75
    • Bird, J.M.1    Owen, R.G.2    D'Sa, S.3
  • 13
    • 84857444683 scopus 로고    scopus 로고
    • Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress [in French]
    • Bridoux F., Delbes S., Sirac C., et al. Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress [in French]. Presse Med 2012, 41:276-289.
    • (2012) Presse Med , vol.41 , pp. 276-289
    • Bridoux, F.1    Delbes, S.2    Sirac, C.3
  • 14
    • 0025269491 scopus 로고
    • Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy
    • Johnson W.J., Kyle R.A., Pineda A.A., et al. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990, 150:863-869.
    • (1990) Arch Intern Med , vol.150 , pp. 863-869
    • Johnson, W.J.1    Kyle, R.A.2    Pineda, A.A.3
  • 15
    • 54949089153 scopus 로고    scopus 로고
    • Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients
    • Soares S.M., Fervenza F.C., Lager D.J., et al. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis 2008, 52:1079-1083.
    • (2008) Am J Kidney Dis , vol.52 , pp. 1079-1083
    • Soares, S.M.1    Fervenza, F.C.2    Lager, D.J.3
  • 16
    • 78049308138 scopus 로고    scopus 로고
    • The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies
    • Fish R., Pinney J., Jain P., et al. The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. Clin J Am Soc Nephrol 2010, 5:1977-1980.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 1977-1980
    • Fish, R.1    Pinney, J.2    Jain, P.3
  • 17
    • 0024994777 scopus 로고
    • Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma
    • Ivanyi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990, 114:986-987.
    • (1990) Arch Pathol Lab Med , vol.114 , pp. 986-987
    • Ivanyi, B.1
  • 18
    • 79957706775 scopus 로고    scopus 로고
    • Early reduction of serum-free light chains associates with renal recovery in myeloma kidney
    • Hutchison C.A., Cockwell P., Stringer S., et al. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 2011, 22:1129-1136.
    • (2011) J Am Soc Nephrol , vol.22 , pp. 1129-1136
    • Hutchison, C.A.1    Cockwell, P.2    Stringer, S.3
  • 19
    • 77950233020 scopus 로고    scopus 로고
    • Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease
    • Lorenz E.C., Sethi S., Poshusta T.L., et al. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease. Nephrol Dial Transplant 2010, 25:1340-1343.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1340-1343
    • Lorenz, E.C.1    Sethi, S.2    Poshusta, T.L.3
  • 20
    • 0034911594 scopus 로고    scopus 로고
    • Renal monoclonal immunoglobulin deposition disease: the disease spectrum
    • Lin J., Markowitz G.S., Valeri A.M., et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 2001, 12:1482-1492.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1482-1492
    • Lin, J.1    Markowitz, G.S.2    Valeri, A.M.3
  • 21
    • 0035007762 scopus 로고    scopus 로고
    • Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate
    • Markowitz G.S., Appel G.B., Fine P.L., et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 2001, 12:1164-1172.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1164-1172
    • Markowitz, G.S.1    Appel, G.B.2    Fine, P.L.3
  • 22
    • 0036439015 scopus 로고    scopus 로고
    • Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma
    • Desikan R., Veksler Y., Raza S., et al. Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. Br J Haematol 2002, 119:496-499.
    • (2002) Br J Haematol , vol.119 , pp. 496-499
    • Desikan, R.1    Veksler, Y.2    Raza, S.3
  • 23
    • 84965004802 scopus 로고
    • MRC working party on leukaemia in adults
    • Analysis and management of renal failure in fourth MRC myelomatosis trial
    • MRC working party on leukaemia in adults. Br Med J 1984, 288:1411-1416. Analysis and management of renal failure in fourth MRC myelomatosis trial.
    • (1984) Br Med J , vol.288 , pp. 1411-1416
  • 24
    • 0031444110 scopus 로고    scopus 로고
    • Presentation and survival of patients with severe renal failure and myeloma
    • Irish A.B., Winearls C.G., Littlewood T. Presentation and survival of patients with severe renal failure and myeloma. Q J Med 1997, 90:773-780.
    • (1997) Q J Med , vol.90 , pp. 773-780
    • Irish, A.B.1    Winearls, C.G.2    Littlewood, T.3
  • 25
    • 0027942872 scopus 로고
    • Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases
    • Blade J., Lust J.A., Kyle R.A. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 1994, 12:2398-2404.
    • (1994) J Clin Oncol , vol.12 , pp. 2398-2404
    • Blade, J.1    Lust, J.A.2    Kyle, R.A.3
  • 26
    • 84860580187 scopus 로고    scopus 로고
    • Treating myeloma cast nephropathy without treating myeloma
    • Leung N. Treating myeloma cast nephropathy without treating myeloma. J Clin Invest 2012, 122:1605-1608.
    • (2012) J Clin Invest , vol.122 , pp. 1605-1608
    • Leung, N.1
  • 27
    • 0017579659 scopus 로고
    • Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function
    • Woodruff R., Sweet B. Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function. Aust N Z J Med 1977, 7:60-62.
    • (1977) Aust N Z J Med , vol.7 , pp. 60-62
    • Woodruff, R.1    Sweet, B.2
  • 28
    • 84860553777 scopus 로고    scopus 로고
    • Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model
    • Ying W.Z., Allen C.E., Curtis L.M., et al. Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model. J Clin Invest 2012, 122:1777-1785.
    • (2012) J Clin Invest , vol.122 , pp. 1777-1785
    • Ying, W.Z.1    Allen, C.E.2    Curtis, L.M.3
  • 29
    • 53649091574 scopus 로고    scopus 로고
    • Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
    • Hutchison C.A., Plant T., Drayson M., et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol 2008, 9:11.
    • (2008) BMC Nephrol , vol.9 , pp. 11
    • Hutchison, C.A.1    Plant, T.2    Drayson, M.3
  • 30
    • 79958826321 scopus 로고    scopus 로고
    • Serum FLC levels can be reduced rapidly; lower levels are associated with renal recovery
    • Drayson M.T., Behrens J., Cohen D.R., et al. Serum FLC levels can be reduced rapidly; lower levels are associated with renal recovery. Clin Lymphoma Myeloma 2009, 9:S57-S58.
    • (2009) Clin Lymphoma Myeloma , vol.9
    • Drayson, M.T.1    Behrens, J.2    Cohen, D.R.3
  • 31
    • 0038007193 scopus 로고    scopus 로고
    • Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia
    • Harris E., Behrens J., Samson D., et al. Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol 2003, 122:160-161.
    • (2003) Br J Haematol , vol.122 , pp. 160-161
    • Harris, E.1    Behrens, J.2    Samson, D.3
  • 32
    • 84862937267 scopus 로고    scopus 로고
    • The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis
    • Morgan G.J., Gregory W.M., Davies F.E., et al. The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis. Blood 2012, 119:7-15.
    • (2012) Blood , vol.119 , pp. 7-15
    • Morgan, G.J.1    Gregory, W.M.2    Davies, F.E.3
  • 33
    • 78049507882 scopus 로고    scopus 로고
    • Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study
    • Ludwig H., Adam Z., Hajek R., et al. Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. J Clin Oncol 2010, 28:4635-4641.
    • (2010) J Clin Oncol , vol.28 , pp. 4635-4641
    • Ludwig, H.1    Adam, Z.2    Hajek, R.3
  • 34
    • 77953862198 scopus 로고    scopus 로고
    • The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function
    • Dimopoulos M., Alegre A., Stadtmauer E.A., et al. The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function. Cancer 2010, 116:3807-3814.
    • (2010) Cancer , vol.116 , pp. 3807-3814
    • Dimopoulos, M.1    Alegre, A.2    Stadtmauer, E.A.3
  • 35
    • 79952126085 scopus 로고    scopus 로고
    • Kidney dysfunction during lenalidomide treatment for AL amyloidosis
    • Specter R., Sanchorawala V., Seldin D.C., et al. Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrol Dial Transplant 2011, 26:881-886.
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 881-886
    • Specter, R.1    Sanchorawala, V.2    Seldin, D.C.3
  • 36
    • 0017235212 scopus 로고
    • Successful treatment of myeloma kidney by diuresis and plasmapheresis
    • Feest T.G., Burge P.S., Cohen S.L. Successful treatment of myeloma kidney by diuresis and plasmapheresis. Br Med J 1976, 1:503-504.
    • (1976) Br Med J , vol.1 , pp. 503-504
    • Feest, T.G.1    Burge, P.S.2    Cohen, S.L.3
  • 38
    • 0029100405 scopus 로고
    • Acute myeloma kidney
    • Winearls C.G. Acute myeloma kidney. Kidney Int 1995, 48:1347-1361.
    • (1995) Kidney Int , vol.48 , pp. 1347-1361
    • Winearls, C.G.1
  • 39
    • 0028519859 scopus 로고
    • Pathogenesis and treatment of myeloma kidney
    • Sanders P.W. Pathogenesis and treatment of myeloma kidney. J Lab Clin Med 1994, 124:484-488.
    • (1994) J Lab Clin Med , vol.124 , pp. 484-488
    • Sanders, P.W.1
  • 40
    • 0038187798 scopus 로고    scopus 로고
    • Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis
    • Torregrosa J.V., Moreno A., Mas M., et al. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis. Kidney Int Suppl 2003, 85:S88-S90.
    • (2003) Kidney Int Suppl , vol.85
    • Torregrosa, J.V.1    Moreno, A.2    Mas, M.3
  • 41
    • 49849095031 scopus 로고    scopus 로고
    • Narrative review: furosemide for hypercalcemia: an unproven yet common practice
    • LeGrand S.B., Leskuski D., Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med 2008, 149:259-263.
    • (2008) Ann Intern Med , vol.149 , pp. 259-263
    • LeGrand, S.B.1    Leskuski, D.2    Zama, I.3
  • 42
    • 0026655885 scopus 로고
    • Nasal human calcitonin for tumor-induced hypercalcemia
    • Dumon J.C., Magritte A., Body J.J. Nasal human calcitonin for tumor-induced hypercalcemia. Calcif Tissue Int 1992, 51:18-19.
    • (1992) Calcif Tissue Int , vol.51 , pp. 18-19
    • Dumon, J.C.1    Magritte, A.2    Body, J.J.3
  • 43
    • 0030342522 scopus 로고    scopus 로고
    • Viscosity of paraproteinemic sera
    • Tichy M. Viscosity of paraproteinemic sera. Acta Medica (Hradec Kralove) 1996, 39:41-43.
    • (1996) Acta Medica (Hradec Kralove) , vol.39 , pp. 41-43
    • Tichy, M.1
  • 44
    • 77952646938 scopus 로고    scopus 로고
    • Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review
    • Weide R., Koppler H., Antras L., et al. Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review. J Cancer Res Ther 2010, 6:31-35.
    • (2010) J Cancer Res Ther , vol.6 , pp. 31-35
    • Weide, R.1    Koppler, H.2    Antras, L.3
  • 45
    • 21744455759 scopus 로고    scopus 로고
    • Zoledronic Acid and renal toxicity: data from French adverse effect reporting database
    • Munier A., Gras V., Andrejak M., et al. Zoledronic Acid and renal toxicity: data from French adverse effect reporting database. Ann Pharmacother 2005, 39:1194-1197.
    • (2005) Ann Pharmacother , vol.39 , pp. 1194-1197
    • Munier, A.1    Gras, V.2    Andrejak, M.3
  • 46
    • 33644829447 scopus 로고    scopus 로고
    • Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party
    • Augustson B.M., Begum G., Dunn J.A., et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 2005, 23:9219-9226.
    • (2005) J Clin Oncol , vol.23 , pp. 9219-9226
    • Augustson, B.M.1    Begum, G.2    Dunn, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.